Literature DB >> 21892625

Spinocerebellar ataxia: a rational approach to aetiological diagnosis.

Adrian Degardin1, Dries Dobbelaere, Isabelle Vuillaume, Sabine Defoort-Dhellemmes, Jean-François Hurtevent, Bernard Sablonnière, Alain Destée, Luc Defebvre, David Devos.   

Abstract

The objective of this study was to determine the main causal diagnosis for spinocerebellar ataxia (SCA) in a geographically defined population of ataxia patients and to suggest a rational basis for choosing appropriate clinical and paraclinical assessments. Given the many aetiologies responsible for SCA, the diagnosis requires the performance of a wide range of paraclinical analyses. At present, there is no consensus on the diagnostic value of these examinations. Furthermore, most of the currently available data gathered by reference centres suffer from selection bias. We performed a prospective study of consecutive cerebellar ataxia patients referred by their family doctors to a university hospital in northern France. Multiple system atrophy and obvious secondary causes (e.g. alcoholism) were excluded by our screening process. The patient's family members were also assessed. Of the 204 patients examined, 47% presented autosomal dominant ataxia and 33% presented sporadic ataxia. Autosomal recessive ataxia was rare (8%) and age at onset was significantly earlier for this condition than for other forms. An aetiological diagnosis was established in 44% of patients, a plausible hypothesis could be formed in 13% of cases, and no diagnosis was made in the remaining 44%. Established diagnoses included SCA1, SCA2, SCA3 and SCA6 mutations, Friedreich's ataxia, and one rare case of ataxia associated with anti-glutamic acid decarboxylase antibodies. Two families presented ataxia associated with autosomal, dominant, optic atrophy with an OPA1 mutation. Mitochondrial diseases were suspected in about 10% of patients. In SCA, reliable determination of the transmission mode always requires the assessment of family members. Mitochondrial disease may be an emerging cause of ataxia. Metabolite assays appeared to be of little value when systematically performed and so should be prescribed only by metabolic disorder specialists in selected cases of sporadic and recessive ataxia. Ophthalmological examination was the most helpful physiological assessment.

Entities:  

Mesh:

Year:  2012        PMID: 21892625     DOI: 10.1007/s12311-011-0310-1

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  33 in total

1.  SANDO: two novel mutations in POLG1 gene.

Authors:  Miguel Fernandes Gago; M J Rosas; Joana Guimarães; Mariana Ferreira; Laura Vilarinho; Lígia Castro; Stirling Carpenter
Journal:  Neuromuscul Disord       Date:  2006-08-21       Impact factor: 4.296

2.  Vitamin E deficiency ataxia with (744 del A) mutation on alpha-TTP gene: genetic and clinical peculiarities in Moroccan patients.

Authors:  Naima Marzouki; Ali Benomar; Mohamed Yahyaoui; Nezha Birouk; Mohamed Elouazzani; Taib Chkili; Mohamed Benlemlih
Journal:  Eur J Med Genet       Date:  2005-02-19       Impact factor: 2.708

Review 3.  Clinical features and molecular genetics of autosomal recessive cerebellar ataxias.

Authors:  Brent L Fogel; Susan Perlman
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182

4.  Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.

Authors:  J Honnorat; A Saiz; B Giometto; A Vincent; L Brieva; C de Andres; J Maestre; N Fabien; A Vighetto; R Casamitjana; C Thivolet; B Tavolato; J Antoine; P Trouillas; F Graus
Journal:  Arch Neurol       Date:  2001-02

5.  The clinical diagnosis of autosomal dominant spinocerebellar ataxias.

Authors:  Thomas Klockgether
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

6.  Antigliadin antibodies in Huntington's disease.

Authors:  Khalafalla O Bushara; Martha Nance; Christopher M Gomez
Journal:  Neurology       Date:  2004-01-13       Impact factor: 9.910

7.  Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients.

Authors:  Won Yong Lee; Dong Kyu Jin; Myung Ryurl Oh; Ji Eun Lee; Seng Mi Song; Eun Ah Lee; Gyeong-Moon Kim; Jin Sang Chung; Kwang Ho Lee
Journal:  Arch Neurol       Date:  2003-06

8.  Second consensus statement on the diagnosis of multiple system atrophy.

Authors:  S Gilman; G K Wenning; P A Low; D J Brooks; C J Mathias; J Q Trojanowski; N W Wood; C Colosimo; A Dürr; C J Fowler; H Kaufmann; T Klockgether; A Lees; W Poewe; N Quinn; T Revesz; D Robertson; P Sandroni; K Seppi; M Vidailhet
Journal:  Neurology       Date:  2008-08-26       Impact factor: 9.910

9.  Cerebellar ataxia and coenzyme Q10 deficiency.

Authors:  C Lamperti; A Naini; M Hirano; D C De Vivo; E Bertini; S Servidei; M Valeriani; D Lynch; B Banwell; M Berg; T Dubrovsky; C Chiriboga; C Angelini; E Pegoraro; S DiMauro
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

10.  OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes.

Authors:  Patrizia Amati-Bonneau; Maria Lucia Valentino; Pascal Reynier; Maria Esther Gallardo; Belén Bornstein; Anne Boissière; Yolanda Campos; Henry Rivera; Jesús González de la Aleja; Rosanna Carroccia; Luisa Iommarini; Pierre Labauge; Dominique Figarella-Branger; Pascale Marcorelles; Alain Furby; Katell Beauvais; Franck Letournel; Rocco Liguori; Chiara La Morgia; Pasquale Montagna; Maria Liguori; Claudia Zanna; Michela Rugolo; Andrea Cossarizza; Bernd Wissinger; Christophe Verny; Robert Schwarzenbacher; Miguel Angel Martín; Joaquín Arenas; Carmen Ayuso; Rafael Garesse; Guy Lenaers; Dominique Bonneau; Valerio Carelli
Journal:  Brain       Date:  2007-12-24       Impact factor: 13.501

View more
  5 in total

1.  Cerebellar ataxia and severe muscle CoQ10 deficiency in a patient with a novel mutation in ADCK3.

Authors:  E Barca; O Musumeci; F Montagnese; S Marino; F Granata; D Nunnari; L Peverelli; S DiMauro; C M Quinzii; A Toscano
Journal:  Clin Genet       Date:  2016-02-16       Impact factor: 4.438

Review 2.  The genetics of ataxia: through the labyrinth of the Minotaur, looking for Ariadne's thread.

Authors:  M Mancuso; D Orsucci; G Siciliano; U Bonuccelli
Journal:  J Neurol       Date:  2014-09       Impact factor: 4.849

Review 3.  The role of gene variants in the pathogenesis of neurodegenerative disorders as revealed by next generation sequencing studies: a review.

Authors:  Shirley Yin-Yu Pang; Kay-Cheong Teo; Jacob Shujui Hsu; Richard Shek-Kwan Chang; Miaoxin Li; Pak-Chung Sham; Shu-Leong Ho
Journal:  Transl Neurodegener       Date:  2017-10-06       Impact factor: 8.014

4.  How to tackle tremor - systematic review of the literature and diagnostic work-up.

Authors:  A W G Buijink; M F Contarino; J H T M Koelman; J D Speelman; A F van Rootselaar
Journal:  Front Neurol       Date:  2012-10-23       Impact factor: 4.003

5.  Autosomal-recessive cerebellar ataxia caused by a novel ADCK3 mutation that elongates the protein: clinical, genetic and biochemical characterisation.

Authors:  Yo-Tsen Liu; Joshua Hersheson; Vincent Plagnol; Katherine Fawcett; Kate E C Duberley; Elisavet Preza; Iain P Hargreaves; Annapurna Chalasani; Matilde Laurá; Nick W Wood; Mary M Reilly; Henry Houlden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-11-11       Impact factor: 10.154

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.